Stay updated on Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial

Sign up to get notified when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a version upgrade to v3.2.0; removed the previous v3.1.0 marker.
    Difference
    12%
    Check dated 2025-10-05T04:53:04.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T02:48:22.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.0.2 replaces v3.0.1, indicating a patch update; the 'Back to Top' link was removed. No other substantive content changes were detected.
    Difference
    0.7%
    Check dated 2025-09-13T17:16:14.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-06T14:46:08.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    14%
    Check dated 2025-08-30T11:26:35.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:33:14.000Z thumbnail image

Stay in the know with updates to Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.